Addus director granted 1,449 restricted shares

Weaver Susan T reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Weaver Susan T reported acquisition or exercise transactions in this Form 4 filing.

Addus HomeCare Corp director Susan T. Weaver received a grant of 1,449 shares of restricted common stock as compensation. These restricted shares were granted to a non-employee director and will vest in full on June 10, 2027. Following this award, Weaver directly holds 13,744 shares of Addus HomeCare common stock.

Insights

Equity compensation analyst

Director receives routine restricted stock grant vesting in 2027.

Director Susan T. Weaver was awarded 1,449 restricted shares of Addus HomeCare Corp common stock at no cash cost, a typical equity component of non-employee director compensation. Such awards align director interests with shareholders by tying value to future share performance.

The shares will vest in full on June 10, 2027, meaning Weaver must remain a director until that date to receive unrestricted ownership. After the grant, she directly holds 13,744 shares. With no open-market buying or selling reported, this filing mainly documents compensation rather than a trading signal.

Insider Trade Summary

Grant/Award: 1,449 shares

Grant/Award 1 txn

Insider Weaver Susan T

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,449	$0.00	$0.00

Holdings After Transaction: Common Stock — 13,744 shares (Direct)

Footnotes (1)

1. F1. Restricted shares granted to non-employee directors that will vest in full on June 10, 2027.

Key Figures

Restricted shares granted: 1,449 shares Holdings after transaction: 13,744 shares Grant price per share: $0.0000 per share +1 more

4 metrics

Restricted shares granted 1,449 shares Grant of restricted common stock to non-employee director

Holdings after transaction 13,744 shares Director’s direct common stock ownership after grant

Grant price per share $0.0000 per share Equity award with no cash paid by director

Vesting date June 10, 2027 Restricted shares vest in full on this date

Key Terms

Restricted shares, non-employee directors, Grant, award, or other acquisition

3 terms

Restricted shares financial

"Restricted shares granted to non-employee directors that will vest in full on June 10, 2027."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

non-employee directors financial

"Restricted shares granted to non-employee directors that will vest in full on June 10, 2027."

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Addus HomeCare Corp (ADUS) report in this Form 4 filing?

Addus HomeCare Corp reported that director Susan T. Weaver received a grant of 1,449 restricted shares of common stock. The award is part of non-employee director compensation and increases her direct holdings to 13,744 shares after the transaction.

Was the Addus HomeCare (ADUS) Form 4 transaction a buy or a sale?

The Form 4 reports an acquisition of shares by director Susan T. Weaver through a grant/award, coded "A". It is not an open-market purchase or sale; instead, it represents equity compensation granted by the company to a non-employee director.

How many Addus HomeCare (ADUS) shares does Susan T. Weaver now own?

After the reported Form 4 transaction, director Susan T. Weaver directly owns 13,744 shares of Addus HomeCare common stock. This total includes the newly granted 1,449 restricted shares, which are subject to vesting conditions through June 10, 2027.

When do Susan T. Weaver’s restricted Addus HomeCare (ADUS) shares vest?

The 1,449 restricted shares granted to director Susan T. Weaver will vest in full on June 10, 2027. Vesting means the restrictions lapse on that date, and she then fully owns the shares, assuming continued service as a non-employee director.

What does the restricted stock grant mean for Addus HomeCare (ADUS) investors?

The grant shows routine equity compensation for a non-employee director, aligning incentives with shareholders. It does not involve open-market buying or selling. The filing mainly indicates ongoing use of stock-based compensation rather than signaling a change in insider sentiment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weaver Susan T

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TEXAS 75034

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		1,449(1)	A	$0	13,744	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted to non-employee directors that will vest in full on June 10, 2027.

	/s/ Brian Poff, Attorney-In-Fact for Susan T. Weaver	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)